This is not the most recent version of the article. View current version (25 JUN 2015)

Intervention Protocol

Propofol versus thiopental sodium for the treatment of refractory status epilepticus

  1. Hemanshu Prabhakar1,*,
  2. Ashish Bindra1,
  3. Gyaninder Pal Singh1,
  4. Mani Kalaivani2

Editorial Group: Cochrane Epilepsy Group

Published Online: 6 JUL 2011

DOI: 10.1002/14651858.CD009202


How to Cite

Prabhakar H, Bindra A, Singh GP, Kalaivani M. Propofol versus thiopental sodium for the treatment of refractory status epilepticus (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No.: CD009202. DOI: 10.1002/14651858.CD009202.

Author Information

  1. 1

    All India Institute of Medical Sciences, Department of Neuroanaesthesiology, New Delhi, India

  2. 2

    All India Institute of Medical Sciences, Department of Biostatistics, New Delhi, India

*Hemanshu Prabhakar, Department of Neuroanaesthesiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India. prabhakaraiims@yahoo.co.in.

Publication History

  1. Publication Status: New
  2. Published Online: 6 JUL 2011

SEARCH

This is not the most recent version of the article. View current version (25 JUN 2015)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the efficacy, adverse effects, short- and long-term outcomes of SE treated with one of the two anaesthetic agents, thiopentone sodium or propofol.